Combined Genetic and Chemical Screens Indicate Protective Potential for EGFR Inhibition to Cardiomyocytes under Hypoxia

Scientists screened for targets for the treatment of ischemia–reperfusion injury using a combination of shRNA and drug library analyses in HL-1 mouse cardiomyocytes subjected to hypoxia and reoxygenation.